Skyhawk Therapeutics
生物技术研究
Waltham，Massachusetts 9,985 位关注者
We Use Small Molecules To Modify RNA Splicing
About Skyhawk Therapeutics
Our mission is to revolutionize disease treatment by developing small molecule therapeutics that correct RNA expression. Skyhawk’s novel approach corrects the underlying genetics of disease at the mRNA level. Our drugs can modify expression of target genes previously considered undruggable for a variety of diseases such as cancer, neurogenerative, autoimmune, inflammatory, and infectious diseases.
Visit Our Website Skyhawk on TwitterWorking at Skyhawk Therapeutics
Our employees are fundamental to our success & we continue to attract & retain people with different experiences & backgrounds. We have a high-performing, collaborative culture characterized by respectful & diverse teams who are committed to our patients first mission. You will have the opportunity to have impact, work with some of the brightest minds in the industry, develop your professional career & contribute to breakthrough medicines for patients with urgent unmet medical needs.
Our Open Roles!Skyhawk Therapeutics Basel, Switzerland
Basel is a city with over 100 years of history in pharmaceutical research and national life sciences. It's clustered with 2/3rd of it's people working in life sciences, 700+ life sciences companies, 3.4% of national GDP invested in R&D (#4 worldwide) and houses the highest % people with a PhD in Europe!
Open Roles in Basel!